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Purpose: The aim of this study was to assess the efficiency and reliability of the 23-gauge 
(23G) transconjunctival vitrectomy system and examine possible complications of this surgi-
cal technique in a variety of vitreoretinal conditions along with early postoperative intraocular 
pressure (IOP) changes.
Materials and methods: A total of 350 eyes of 324 patients having undergone 23G transconjunc-
tival vitrectomy were included in this prospective study. A total of 150 (46.2%) were male and 174 
(53.8%) female, with a mean age of 61.28 ± 15.67 years. Mean follow-up time was 8.3 months.
Results: Mean BCVA logMARs were as follows: preoperatively 0.839 ± 0.59, postoperatively 
first day  2.07 ± 0.76, first week 1.14 ± 0,43, first month 0.63 ± 0.26 and last examination 0.359 ± 
0.17. Mean BCVA decreased significantly (P , 0.001, P , 0.028, respectively) on postoperative 
first day and  first week, mainly due to air or gas tamponade, and increased significantly in the 
first month and final control in almost all  indications (P , 0.001). Postoperative mild hypotony 
(IOP # 10 mmHg) was detected in 112 (32%) eyes on day 1 and in 59 (16.8%) eyes in week 1. 
While postoperative serious hypotony (#5 mmHg) was detected in 34 (9.7%) eyes on day 1, it 
was not detected in any eyes at the end of the first week. None of the eyes required an additional 
gas tamponade or any other procedure in the early postoperative period due to   hypotony. A total 
of 13 (3.7%) eyes were reoperated for recurrent vitreous hemorrhage; 23 (6.5%) eyes were 
reoperated on a second time, nine (2.5%) a third time, and 1 (0.2%) a fourth time for recurrent 
rhegmatogenous retinal detachment. Postoperative fibrinoid reaction was seen in 17 (4.8%) eyes 
on the first day and responded well to the medications. Cataract development was found in 61 
(22.5%) of the 270 phakic eyes after a mean duration of 6.4 ± 3.5 months. Anatomical success 
was obtained in 86% of the patients and functional success in 72%.
Conclusion: The 23G transconjunctival vitrectomy system is safe and effective in a wide 
field of vitreoretinal conditions. It is a good alternative to 20G and 25G techniques but needs 
some improvement mainly in regards to the instruments and related techniques; further larger 
controlled group studies are needed.
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Introduction
Technological advancements in vitreoretinal surgery have made it possible to surgi-
cally treat certain diseases which had been considered hard for a long time. Invented 
by Machemer in the early 1970s, the “pars plana vitrectomy” technique has led to 
an increasingly more advanced and promising treatment, which calls for limited 
  intervention. Introduced for the first time by Claus Eckardt, the 23-gauge (23G) 
transconjunctival vitrectomy technique is commonly accepted by vitreoretinal surgeons 
in daily practice. In this study, the outcomes of 350 cases of 23G pars plana   vitrectomies Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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with different etiologies performed at the I ˙stanbul Training 
and Research Hospital, Ophthalmology Clinic were assessed. 
The aim was to assess the efficiency and reliability of the 23G 
transconjunctival vitrectomy system and examine possible 
complications of this surgical technique along with early 
postoperative intraocular pressure (IOP) changes.
Materials and methods
Between November 2005 and December 2007, 23G transcon-
junctival vitrectomy was performed in the clinic on 350 eyes 
of 324 patients. In this prospective study, all 350 eyes of 
these 150 male (46.2%) and 174 female (53.8%) patients 
were examined. Mean follow-up time was 8.3 months 
(4–48 months). Mean age was 61.28 ± 15.67 years. Informed 
consent according to the Declaration of Helsinki were taken 
prior to surgery. The vitrectomy indications in the study are 
indicated in Table 1.
Best-corrected visual acuity (BCVA) was measured 
using the ETDRS (Early Treatment Diabetic Retinopathy 
Study) and Snellen charts. For ease of analysis, visual acu-
ity was turned into logMAR (logarithm of the minimum 
angle of resolution) scores. IOP measurements were made 
with Goldmann applanation tonometry. IOP # 10 mmHg 
was considered as mild hypotony and #5 mmHg as serious 
hypotony. Biomicroscopic findings regarding the cornea, 
conjunctiva, and anterior chamber were noted. The fundu-
scopic examination was carried out by contact lenses and 
binocular indirect ophthalmoscope. In cases where fundus 
imaging was not possible, mode A and B ultrasonographic 
examination was undertaken. In this series, B-mode ultra-
sonographic examination was undertaken on all eyes with 
vitreous hemorrhage (VH) in the preoperative period. All 
patients with vitreomacular surface disorders were examined 
with the Stratus OCT™ III (Carl Zeiss Meditec Inc, Dublin, 
CA) device. Intraoperative or postoperative complications 
such as leakage from sclerotomy, hemorrhage, vitreous or 
retinal incarceration, retinal detachment at transconjunctival 
entry, or dialysis were noted. Goldmann three-mirror and 
extreme wide field contact lenses were used to evaluate the 
vitreous base.
Retinal detachment, vitreous or suprachoroidal hemor-
rhage, choroidal detachment or folds, and endophthalmitis 
incidence was assessed. Anti-vascular endothelial growth fac-
tor was injected into some diabetic VH and diabetic tractional 
retinal detachment (DTRD) cases 2–7 days before surgery, 
and in one case at the beginning only of the operation.
The operations were performed under local or general 
anesthesia. Sclerotomies were performed from upper 
temporal, lower temporal, and upper nasal quadrants, 3.0, 
3.5, and 4.0 mm from the corneoscleral limbus in aphakic, 
pseudophakic, and phakic cases, respectively, by using a 
23G microvitreoretinal knife parallel to the limbus and at an 
angle. In order to prevent postoperative leakage, the scleral 
tunnel that formed in the sclerotomy with this technique was 
moved slightly to the conjunctiva with the help of a special 
fixation technique known as conjunctival fixation (Figure 1). 
The first microcannula was inserted in the lower temporal 
sclerotomy, followed by infusion. Balanced saline solution 
was used as the infusion fluid (Figure 2). Air, expansile 
gas, or silicone oil (1000 centistokes, 5000 centistokes) 
was used as endotamponade when necessary;   hexafluoride 
(SF6) was used in 60 (17.1%) eyes, perfluoropropane 
(C3F8) in 105 (30%) eyes, silicone oil in 65 (18.7%) eyes, 
and air in 74 (21.1%) eyes; 46 (13.1%) eyes were left with 
fluid. Silicone oil was injected after the fluid-air or fluid 
PFC – silicone exchange in some of the cases, without 
enlarging the sclerotomies.
Peripheral iridectomy at the 6 o’clock position was per-
formed in aphakic eyes before silicone oil tamponade. Any 
sclerotomy leaking air, gas, liquid, or especially silicone oil 
was sutured with 7/0 vicryl at the end of surgery.
Table 1 23 Gauge vitrectomy indications
(n) (%)
retinal detachment (rrD) 98 28
intravitreal hemorrhage (iVH) 80 22.8
Proliferative diabetic retinopathy and membranes (DTrD) 62 17.7
idiopathic and secondary epiretinal membranes (erM) 54 15.4
Macular hole (MH) 27 7.7
Vitreomacular traction (VMT) 8 2.2
endophthalmitis 7 2
Dislocations of the lens particles to vitreous 7 2
Vitreous opacities 7 2
Figure 1 Trocar and infusion canula positions in 23 gauge vitrectomy.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Subconjunctival antibiotics and steroid injections were 
administered at the end of surgery. Statistical analyses were 
done by using SPSS Statistics (IBM Corporation, Somers, NY) 
software, version 11.5 for Windows. The difference between 
pre- and postoperative visual acuity and IOP levels were com-
pared by using two-tailed paired t-test. Results with a P-value 
below 0.05 were considered statistically significant.
Results
Mean BCVA logMARs were as follows: preoperatively 0.839 
± 0.59, postoperatively first day  2.07 ± 0.76, first week 1.14 
± 0,43, first month 0.63 ± 0.26 and last examination 0.359 ± 
0.17. Mean BCVA decreased significantly (P , 0.001, P , 
0.028, respectively) on postoperative first day and  first week, 
mainly due to air or gas tamponade, and increased signifi-
cantly in the first month and final control (P , 0.001). 
Preoperative BCVA logMARs were 0.658 (3.10–0) in 
RRD, 1.155 (3.10–0.4) in IVH, 1.046 (3.10–0.4) in DTRD, 
0.495 (1.0–0.22) in ERM, 0.796 (1.10–0.3) in MH, 0.538 
(1.10–0.15) in VMT, 1.699 (3.10–0.4) in endophtalmitis, 
0.620 (3.10–0) in dislocations of the lens particles, 0.456 
(1.0–0.3) in vitreous opacities. 
Postoperative final BCVA logMARs were 0.337 (3.10–0) 
in RRD, 0.276 (3.10–0) in IVH, 0.620 (3.10–1.125) in 
DTRD, 0.237(1.0–0) in ERM, 0.420 (1.10–0.3) in MH, 0.222 
(1.10–0.15) in VMT, 0.658 (3.10–0.22) in endophtalmitis, 
0.108 (3.10–0) in dislocations of the lens particles and 0.143 
(1.0–0.05) in vitreous opacities (Table 2).
Mean intraocular pressure values for all patients prior to 
the operation was 14.75 ± 7.1, followed by the postoperative 
day 1 value of 11.62 ± 9.7 (P , 0.001), postoperative week 1 
value of 15.86 ± 6.6 (P = 0.330), and postoperative month 1 
value of 16.84 ± 5.6 (P = 0.556). Last postoperative mean 
intraocular pressure was 15.1 ± 3.9 (P = 0.306).
Postoperative mild hypotony (IOP # 10 mmHg) was 
detected in 112 (32%) eyes on day 1 and in 59 (16.8%) eyes 
in week 1. While postoperative serious hypotony (#5 mmHg) 
was detected in 34 (9.7%) eyes on day 1, it was not detected 
in any eyes at the end of the first week. None of the eyes 
required an additional gas tamponade or any other procedure 
in the early postoperative period due to hypotony. During the 
follow-up, no choroidal effusion, detachment, or folds devel-
oped, and no vitreous incarceration around the wound was 
noted. Single sclerotomies of four patients who had nucleus 
fragments in the vitreous cavity were changed to 20G for pha-
cofragmentation, as a 23G phacofragmentation probe was not 
available at that time. In all macular hole (MH) cases (stages 
2–4), internal limiting membrane peeling and fluid/air/gas 
exchange were performed. Postoperative optical coherence 
tomography (OCT) revealed opening of the MH in five 
(18.1%) eyes after a mean duration of 3.73 ± 2.92 months. 
Figure 2 Specially designed pressure plate for holding the conjunctiva.
Table 2 Mean preoperative and postoperative visual acuities
N (%) Preoperative VA  
(logMAR)
Postoperative VA final  
(logMAR)
P
rrD 98 (28) 0.658 0.337 ,0.001
iVH 80 (22.9) 1.155 0.276 ,0.001
DTrD 62 (17.7) 1.046 0.620 ,0.001
erM 54 (15.4) 0.495 0.237 ,0.001
MH 27 (7.7) 0.796 0.420 ,0.001
VMT 8 (2.3) 0.538 0.222 ‡
endophthalmitis 7 (2) 1.699 0.658 ‡
Dislocations of the lens particles to vitreous 7 (2) 0.620 0.108 ‡
Vitreous opacities 7 (2) 0.456 0.143 ‡
Notes: ‡ Low number of patients.
Abbreviations: VA, visual acuity; rrD, rhegmatogenous retinal detachment; iVH, intravitreal hemorrhage; DTrD, diabetic tractional retinal detachment; erM, epiretinal 
membrane; MH, macular hole; VMT, vitreomacular traction.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Holes of four were closed after the second 23G pars plana 
vitrectomy. All grades of retinal detachments were submit-
ted to 23G pars plana vitrectomy. Advanced proliferative 
vitreoretinopathy cases had combined lens surgery, radial 
retinotomies of up to 360°, retinectomies, and/or encircling 
scleral buckles. In some DTRD cases, bimanual surgery 
was performed.
Among the rhegmatogenous retinal detachment (RRD) 
patients, 68 were given C3F8 gas and 44 were given   silicone 
oil tamponade in the primary surgery. Of the 98 cases, 
23 (6.5%) eyes were reoperated on a second time, nine (2.5%) 
a third time, and one (0.2%) a fourth time for recurrent RRD. 
Encircling scleral buckles were used in 13 (3.5%) of those 
cases. In some of the 11 cases (3.1%) who had silicone leakage 
either outside and/or under the conjunctiva after the removal 
of trocars, silicone oil was found inadequate in the vitreous 
cavity in the postoperative period. It was noted that recurrence 
was mostly observed in these patients.   Anatomical and func-
tional success rates were obtained from the patients’ last visit 
findings. Anatomical success was defined as:   reattachment of 
retinal detachments until the final visit, relieving of tractional 
detachments of DTRDs, cleaning of VHs, vitreous opacities, 
and nuclear fragments; closure of MHs; absence of epiretinal 
membranes (ERMs) and vitreomacular traction syndrome 
(VMT) confirmed by OCT. On the other hand, functional 
success was defined as BCVA of Snellen 1/20 (logMAR 1.3) 
or better on last follow-up and no reduction in visual acuity 
as compared with the preoperative period.
Functional success, on the other hand, was defined as 
BCVA of 1/20 or higher on last follow-up and no reduc-
tion in vision as compared with the preoperative period. 
  Evaluated according to these success criteria, anatomical 
success was obtained in 86% of the patients and functional 
success in 72%. Revitrectomy was performed in 13 (3.7%) 
diabetic patients for intravitreous bleed. It was thought 
that the major reasons were because of mild or serious 
hypotony and inadequate peripheral vitreous dissection and 
inadequate peripheral laser photocoagulation, especially in 
the phakic eyes.
Of the 350 patients, 270 were phakic. On postoperative 
follow-up, cataract was found in 61 (22.5%) of the 270   phakic 
eyes after a mean duration of 6.4 ± 3.5 months. Of these 
patients, 52 underwent phacoemulsification and intraocular 
lens implantation, and nine were left aphakic. Sclerotomy 
had to be shifted to 20G for comfortable tool manipulation in 
four eyes that had lens fragmentation in the vitreous. Fibrin 
reaction was observed in the anterior chamber of 17 (4.8%) 
eyes on the first postoperative day. These all had resolution by 
pupillary dilatation, steroid treatment, and fortified antibiotic 
eyedrops during the follow-up.
Discussion
The 20G vitrectomy technique has been a widely accepted 
technique by surgeons for more than 20 years. It is quite effec-
tive in cleaning thick hemorrhages, and fibrous bands and has 
large clinical application potential. However, transconjunc-
tival techniques are starting to be preferred due to shorter 
operation time, less need of suturing, less postoperative 
inflammation, and less pain.
Developed recently by Fujii et al,5 the transconjunctival 
unsutured vitrectomy technique is one of the most important 
advances of vitreoretinal surgery. Owing to the thinness of 
25G instruments, sclera recovery can be achieved without 
needing sutures. Therefore, suture-related astigmatism and 
discomfort can be eliminated. As is widely known, sutures 
used without covering the sclerotomy area cause irritation 
and pigmentation in the sclerotomy area. Thirty-two percent 
local inflammatory reaction is reported with Dacron and 5% 
with polyglycolic acid. With unsutured surgery, suture-related 
irritation and local inflammatory reaction can be prevented. 
Various previous studies have stated that unsutured small-
incision cataract surgery reduces postoperative inflammatory 
reaction.1–3 Karaçorlu et al compared 14 unsutured eyes and 
20 sutured eyes after applying 20G pars plana vitrectomy. 
While the eight patients who were sutured displayed ocular 
surface irritation and one eye displayed scleral pigmentation, 
these complications were not seen in any of the unsutured 
eyes.4 It is believed that, when compared with conventional 
pars plana vitrectomy, 25G unsutured vitrectomy causes 
less postoperative inflammation and faster postoperative 
recovery.5,6 Rizzo et al compared 25G unsutured vitrectomy 
and 20G pars plana vitrectomy in ERM cases and concluded 
that 25G unsutured vitrectomy caused less postoperative 
inflammatory reaction and thus allowed faster rehabilitation.7 
In addition, discomfort levels in 25G unsutured vitrectomy 
patients were also lower. Romero et al compared 25G unsu-
tured vitrectomy and standard 20G vitrectomy with respect 
to inflammation and surgery durations and found that 25G 
unsutured vitrectomy took less time and led to less inflam-
mation after the surgery.8 Likewise, Chen showed that 25G 
unsutured vitrectomy could be performed in a shorter time 
and led to less inflammation in the postoperative stage.9
Vitreous base cleansing takes less time when compared 
with 25G, and silicone oil injection is faster. In their 13 disease 
25G silicone intake series, Kapran and Acar found the mean 
silicone oil injection time to be 7.27 ± 0.48 minutes, did not Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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experience any complications during surgery, and did not need 
additional sutures.10 Although 25G has thinner calibration, 23G 
causes less postoperative hypotony, as oblique entry to the 
sclera is used. The 23G vitrectomy technique also has some 
disadvantages, with postoperative temporary hypotony being 
the most serious one.   However, its rate is lower than for 25G. 
While Kusuhara et al found a postoperative hypotony rate of 
1.5% following 23G vitrectomy in 314 eyes, they found a rate 
of 18.4% after 25G vitrectomy.11 Also, shifting to 20G may 
be necessary in lens dislocations in the vitreous or in certain 
complicated cases such as intense fibrovascular membrane. In 
the present study, the transconjunctival vitrectomy outcomes 
were examined in 350 eyes of 324 patients with intraventricular 
hemorrhage, MH,VMT, ERM, DTRD, RRD, dislocation of 
lens fragments in the   vitreous, and intravitreal opacity. Lakhan-
pal et al recorded the total surgery durations of their series 
of 140 eyes on which they performed 25G vitrectomy, along 
with entry, exit, and vitrectomy times.12 They reported shorter 
total surgery times in 25G vitrectomy as it does not involve the 
stages of conjunctival peritomy and opening and suturing of the 
sclera. In their 23G vitrectomy series, Fine et al found a mean 
opening time of 1.7 minutes, mean closing time of 1.3 min-
utes, and mean procedural time of 24.1 minutes.13 Lakhanpal 
et al attributed longer surgery times to the fact that the 25G 
technique involves two stages.12 Previous studies have reported 
shorter mean total surgery times with unsutured vitrectomy 
than in eyes on which 20G was performed.5,13 In the present 
study, a significant increase in postoperative visual acuity was 
identified in all patients in general. Considering patient groups, 
RRD, intraventricular hemorrhage, DTRP, ERM, and MH had a 
statistically significant increase in visual acuity. Patient groups 
who were admitted to the study due to endophthalmitis, lens 
dislocation in the vitreous, or vitreomacular traction were not 
included in the statistics.
Among patients with gas and air tamponade, mean post-
operative visual acuity was lower on day 1 and in week 1, and 
BCVA was assessed after tamponade resorption. On postop-
erative follow-up, together with the resorption of internal gas 
endotamponade (2–8 weeks), mean visual acuity at month 1 
was elevated as compared with the preoperative value, and the 
elevation continued on last follow-up. Other studies about 23G 
vitrectomy also reveal a statistically significant increase in post-
operative follow-up visual acuity values when compared with 
those in the preoperative stage.7,13 In the present series, low IOP 
did not cause choroidal detachment/folds or endophthalmitis. 
Ibarra et al14 and Yanyali et al15 conducted studies using 25G, 
and both reported a significant decrease in IOP on postopera-
tive day 1, similar to the findings of the present study. Fine 
et al13 detected severe hypotony on postoperative day 1, one of 
their patients required suturing on the same day and choroidal 
effusion did not occur in any of their patients. After they started 
to use 23G vitrectomy, Eckardt stated that the angle of the inci-
sion is more important than its size in preventing postoperative 
hypotony.16 In general, the rate of postoperative hypotony is 
higher in 25G series than in 23G series. Shimada et al found 
hypotony in 20% of the eyes in which they used fluid as endot-
amponade.17 Fujii et al reported an IOP value below 10 mmHg 
in 24% of 64 unsutured vitrectomy patients.5,6 As a result of 
63 operations, Shimada et al found postoperative low IOP in 
9% of the eyes that they left with air or gas endotamponade 
and in 20% of the eyes that they left with fluid.17 In the present 
study, SF6 was used as endotamponade in 60 (17.1%) eyes, 
C3F8 in 105 (30%) eyes, silicone oil in 65 (18.7%) eyes, air 
in 74 (21.1%) eyes, and fluid in 46 (13.1%) eyes. Those that 
were left with fluid were more hypotonic than gas or air, but a 
significant difference did not exist between the postoperative 
hypotony rates of eyes in which different endotamponades 
were applied. This has led to the conclusion that the scleral 
incision technique may be more important than the choice of 
endotamponade type in the prevention of leakage or hypotony. 
As stated by Fine et al,13 Eckardt17 and Avcı and Alyamaç,18 
the 23G vitrectomy technique is a more reliable one than 25G 
and carries fewer complication risks.
In conclusion, 23G transconjunctival vitrectomy system is 
safe and effective in a wide field of vitreoretinal conditions. 
It is a good alternative to 20G and 25G techniques but needs 
some improvement, mainly in regard to the instruments and 
related techniques; further larger controlled group studies 
are needed.
Note
This study was performed at the Istanbul Training and 
Research Hospital, Ophthalmology Clinic.
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